Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
109,5 USD | +1,89% | -0,44% | -11,01% |
Attività
Numero di dipendenti: 2 800
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Pharmaceutical Products
100,0
%
| 3 659 | 100,0 % | 3 834 | 100,0 % | +4,78% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
91,0
%
| 3 370 | 92,1 % | 3 490 | 91,0 % | +3,55% |
Europe
7,0
%
| 240 | 6,5 % | 269 | 7,0 % | +12,35% |
All Other
2,0
%
| 49 | 1,3 % | 75 | 2,0 % | +51,92% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Bruce Cozadd
CEO | Chief Executive Officer | 60 | 01/03/03 |
Renée Galá
PSD | President | 52 | 16/03/20 |
Robert Iannone
CTO | Chief Tech/Sci/R&D Officer | 57 | 29/05/19 |
Seamus Mulligan
BRD | Director/Board Member | 63 | 18/01/12 |
Andrea N. Flynn
IRC | Investor Relations Contact | - | - |
Shawn Mindus
PRN | Corporate Officer/Principal | - | - |
John Miller
PRN | Corporate Officer/Principal | - | - |
Heidi Manna
HRO | Human Resources Officer | 53 | 01/11/18 |
Neena Patil
LAW | General Counsel | 49 | 01/07/19 |
Aislinn Doody
SEC | Corporate Secretary | - | - |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Bruce Cozadd
CEO | Chief Executive Officer | 60 | 01/03/03 |
Norbert Riedel
BRD | Director/Board Member | 66 | 13/05/13 |
Patrick Enright
BRD | Director/Board Member | 62 | 01/01/09 |
Peter Gray
BRD | Director/Board Member | 69 | 08/05/13 |
Ken O'Keefe
BRD | Director/Board Member | 57 | 01/01/04 |
Rick Winningham
BRD | Director/Board Member | 64 | 01/01/10 |
Seamus Mulligan
BRD | Director/Board Member | 63 | 18/01/12 |
Heather McSharry
BRD | Director/Board Member | 62 | 02/05/13 |
Catherine Sohn
BRD | Director/Board Member | 71 | 27/07/12 |
Anne O’Riordan
BRD | Director/Board Member | 56 | 14/02/19 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 62 345 283 | 60 588 007 ( 97,18 %) | 0 | 97,18 % |
Coordinate società
Jazz Pharmaceuticals Plc
Waterloo Exchange Waterloo Road
4, Dublin
+353 1 634 7800
http://www.jazzpharmaceuticals.comSocietà del gruppo
Nome | Categoria e settore |
---|---|
Jazz Pharmaceuticals Ireland Ltd.
Jazz Pharmaceuticals Ireland Ltd. Pharmaceuticals: MajorHealth Technology Part of Jazz Pharmaceuticals Plc, Jazz Pharmaceuticals Ireland Ltd. is an Irish biopharmaceutical company that focuses on the identification, development, and commercialization of pharmaceutical products. The private company is based in Dublin, Ireland. The company was founded by Bruce C. Cozadd, who has been the CEO since incorporation. |
Pharmaceuticals: Major
|
Jazz Financing I DAC
|
Finance/Rental/Leasing
|
Jazz Securities DAC
|
Finance/Rental/Leasing
|
Jazz Investments II Ltd.
|
Finance/Rental/Leasing
|
Jazz Financing Lux SARL
Jazz Financing Lux SARL Finance/Rental/LeasingFinance Part of Jazz Pharmaceuticals Plc, Jazz Financing Lux SARL provides financing services. The private company is based in Luxembourg, Luxembourg. Founded in 2013. |
Finance/Rental/Leasing
|
Jazz Investments Europe Ltd.
| |
Jazz Pharmaceuticals Ireland Holdings Ltd.
| |
Jazz Financing Holdings Ltd.
|
Settore
Vendite per regione
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
-11,01% | 6,82 Mrd | |
+25,83% | 661 Mrd | |
+27,00% | 566 Mrd | |
-6,76% | 352 Mrd | |
+20,34% | 332 Mrd | |
+3,00% | 283 Mrd | |
+13,09% | 231 Mrd | |
+5,46% | 200 Mrd | |
-9,61% | 195 Mrd | |
-6,26% | 145 Mrd |
- Borsa valori
- Azioni
- Azione JAZZ
- Società Jazz Pharmaceuticals plc